BlackRock Fund Advisors - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 45 filers reported holding ATYR PHARMA INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q4 2016$88,000
-92.2%
40,957
-88.4%
0.00%
Q3 2016$1,126,000
+14.9%
354,015
+0.4%
0.00%
Q2 2016$980,000
-46.4%
352,465
-24.1%
0.00%
Q1 2016$1,830,000
-58.1%
464,476
+4.6%
0.00%
-100.0%
Q4 2015$4,364,000
+161.9%
443,937
+173.3%
0.00%
Q3 2015$1,666,000
-43.4%
162,421
+2.2%
0.00%
-100.0%
Q2 2015$2,944,000158,9400.00%
Other shareholders
ATYR PHARMA INC shareholders Q2 2015
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 1,827,992$33,854,00015.10%
EcoR1 Capital, LLC 836,860$15,499,0005.17%
Rock Springs Capital Management LP 408,496$7,565,0000.55%
BVF INC/IL 134,725$2,495,0000.44%
Baker Brothers Advisors 2,335,125$43,247,0000.38%
SPHERA FUNDS MANAGEMENT LTD. 209,027$3,696,0000.36%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 461,530$8,548,0000.28%
MARINER INVESTMENT GROUP LLC 50,665$938,0000.24%
TIVERTON ASSET MANAGEMENT LLC 450,000$8,334,0000.17%
RIVERHEAD CAPITAL MANAGEMENT LLC 415,377$7,693,0000.12%
View complete list of ATYR PHARMA INC shareholders